ARWR vs UPS · rev $829.4M vs P/E 15, rev $88.66B
Arrowhead Pharmaceuticals Inc (ARWR) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was $30.1M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
ARWR currently screens at market cap $10.59B. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the ARWR and UPS stock pages for the full models.
Not investment advice.